BRAINIX Ayurvedic Syrup 200 ml | FARVEDA

BRAINIX Ayurvedic Syrup

  • Home
  • BRAINIX Ayurvedic Syrup
BRAINIX Ayurvedic Syrup

BRAINIX Ayurvedic Syrup

Composition : Ayurvedic Proprietary Medicine.

Packing : 200 ML Pet Bottle

MRP : 150/-

Enquire Now


Can't read the image? click here to refresh

BRAINIX – Ayurvedic Syrup

BRAINIX is an Ayurvedic proprietary medicine from FARVEDA, developed as part of its Ayurvedic healthcare product portfolio. Presented in a 200 ml syrup formulation, the product is positioned in the memory and concentration support segment.

The formulation is categorised as an Ayurvedic brain wellness product, with product positioning centred around memory, concentration and intellectual performance.

Product Specifications

  • Brand Name: BRAINIX

  • Brand Portfolio: FARVEDA

  • Product Type: Ayurvedic Proprietary Medicine

  • Dosage Form: Syrup

  • Packing: 200 ml

  • Product Segment: Memory and Concentration Support

  • Product Category: Ayurvedic Products Range

Product Positioning

BRAINIX is positioned in the Ayurvedic cognitive wellness segment. The product packaging highlights three areas of intended application:

  • Memory support

  • Concentration support

  • Intellectual performance support

Formulation Information

BRAINIX is available as a liquid Ayurvedic proprietary preparation in a 200 ml bottle. Its complete herbal composition, individual ingredient quantities and formulation characteristics should be referred to the approved product label and accompanying product documentation.

Product Information

BRAINIX forms part of the FARVEDA Ayurvedic product portfolio and is presented in a convenient syrup dosage form.

For complete information regarding ingredients, recommended usage, dosage, precautions and storage conditions, refer to the approved product label.

Disclaimer: Product positioning does not establish clinical efficacy. Claims relating to memory improvement, concentration enhancement or intellectual performance should be supported by appropriate product-specific evidence and applicable regulatory authorisation.